CDTX
Companies
NASDAQ
Cidara Therapeutics Inc.
Health Care
$21.31
-$5.57 (-20.72%)
Price Chart
Overview
About CDTX
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Market Cap
$58.6M
Volume
3.7M
Avg. Volume
3.4M
P/E Ratio
-3.444302
Dividend Yield
0.00%
Employees
77.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.11
Moderate Correlation
Volatility
High (0.78)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CDTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$58.6M
Volume3.7M
P/E Ratio-3.44
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025